Lung DCs |
|
|
|
|
|
|
|
|
|
|
|
|
DC % of CD45+ live cells |
-0.03 |
|
0.16 |
|
0.11 |
|
-0.51 |
** |
-0.26 |
|
-0.10 |
|
cDC1 % of CD45+ live cells |
0.50 |
** |
0.47 |
** |
0.38 |
* |
0.12 |
|
0.14 |
|
0.15 |
|
cDC2 % of CD45+ live cells |
0.16 |
|
0.20 |
|
0.17 |
|
-0.29 |
|
-0.17 |
|
-0.09 |
|
moDC % of CD45+ live cells |
0.15 |
|
0.23 |
|
0.20 |
|
-0.37 |
* |
-0.27 |
|
-0.12 |
|
pDC % of CD45+ live cells |
-0.15 |
|
-0.38 |
* |
-0.34 |
|
0.55 |
** |
0.40 |
* |
0.12 |
|
Lung ILCs |
|
|
|
|
|
|
|
|
|
|
|
|
ILC ‰ of CD45+ live cells |
0.33 |
|
0.47 |
* |
0.48 |
** |
-0.12 |
|
-0.06 |
|
0.10 |
|
ILC1 ‰ of CD45+ live cells |
0.06 |
|
-0.19 |
|
0.00 |
|
0.36 |
|
0.45 |
* |
0.37 |
* |
ILC2 ‰ of CD45+ live cells |
0.43 |
* |
0.47 |
** |
0.46 |
* |
-0.06 |
|
-0.04 |
|
0.15 |
|
NCR+ILC3 ‰ of CD45+ live cells |
-0.04 |
|
0.10 |
|
0.33 |
|
0.12 |
|
0.13 |
|
0.08 |
|
NCR-ILC3 ‰ of CD45+ live cells |
-0.18 |
|
0.18 |
|
0.30 |
|
-0.27 |
|
-0.09 |
|
-0.07 |
|